Clinical Problem Solving: Relapsing Cerebral Melioidosis-Reference-Cited by-同舟云学术

Clinical Problem Solving: Relapsing Cerebral Melioidosis

Published:2024-07 Issue:3 Volume:2 Page:145-149
ISSN:2950-4392
Container-title:Journal of Clinical Infectious Disease Society
language:en
Short-container-title:

Author:

Singhal Tanu¹,Kumar Abhaya¹,Nadgouda Kunal¹,Shah Sweta¹,Vyas Navita Purohit¹,Patel Neha¹

Affiliation:

1. Department of Infectious Disease, Neurosurgery, Radiolology, Microbiology and Rehabilitation, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra, India

Abstract

Melioidosis is a disease that is difficult to diagnose and challenging to treat. When it involves the brain, the complexities increase even further. Diagnostic challenges include those related to identification and susceptibility testing. Treatment issues encountered in this patient with neuromelioidosis related to choice and duration of initial intensive therapy and subsequent eradication therapy and their impact on relapse are discussed and highlighted.

Publisher

Medknow

Reference17 articles.

1. Footprints of human melioidosis in the North Western Indian states, expanding endemicity in India;Patel;Indian J Med Microbiol,2021

2. Burden of melioidosis in India and South Asia:Challenges and ways forward;Mohapatra;Lancet Reg Health Southeast Asia,2022

3. 2020 review and revision of the 2015 Darwin melioidosis treatment guideline;paradigm drift not shift;Sullivan;PLoS Negl Trop Dis,2020

4. Management of Burkholderia pseudomallei infections:Recent recommendations on antimicrobial susceptibility testing;Bakthavatchalam;Indian J Med Microbiol,2022

5. A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei;Piliouras;Int J Antimicrob Agents,2002